Clascoterone as a novel treatment for androgenetic alopecia

被引：16

作者：

Sun, H. Y. ^{[1
,2
]}

Sebaratnam, D. F. ^{[1
,2
]}

机构：

[1] Liverpool Hosp, Dept Dermatol, Liverpool, Merseyside, England

[2] Univ New South Wales, Fac Med, Sydney, NSW, Australia

来源：

关键词：

EFFICACY; SAFETY;

D O I：

10.1111/ced.14292

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：913 / 914

页数：2

共 5 条

[1] Cartwright M, 2019, J AM ACAD DERMATOL, V81, pAB13
[2] Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne Two Phase 3 Randomized Clinical Trials
Hebert, Adelaide
Thiboutot, Diane
Gold, Linda Stein
Cartwright, Martina
Gerloni, Mara
Fragasso, Enrico
Mazzetti, Alessandro
[J]. JAMA DERMATOLOGY, 2020, 156 (06) : 621 - 630
[3] Mella JM, 2010, ARCH DERMATOL, V146, P1141, DOI 10.1001/archdermatol.2010.256
[4] Mazzetti A, 2019, J DRUGS DERMATOL, V18, P570
[5] Rosette C, 2019, J DRUGS DERMATOL, V18, P197